Connect with us

Cannabis

Hemp, Inc. Continues Massive Expansion In Florida

Published

on

Las Vegas, NV, April 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, announced today this week marks the one year anniversary of Florida’s state hemp program as the Company continues its massive expansion in the state.  Hemp, Inc. is currently scouting locations for its Kins Communities in order to build numerous hemp growing and processing facilities in Florida due to its booming hemp market estimated to surge to $30 billion, according to Fox Business’ Ashley Webster.  Some are even calling it “the crop of the future”.

According to the news source, “hemp has given a boost to the Sunshine State.” Overseen by the Florida Department of Agriculture and Consumer Services (FDACS), “the department and its Office of Cannabis manage and regulate Florida’s hemp program and cannabis products, including CBD.”

According to Hemp, Inc. executives, Florida’s prime climate is right for hemp so it’s really just a matter of ensuring that there are proper processing facilities once the hemp has been harvested.

Hemp, Inc. is in the initial stages of establishing hemp processing facilities, which have been a strong suit of the company given their success in other states, and the Company plans on equipping Florida hemp farmers with the infrastructure they need to ensure the success of hemp in the state. Thus far, “hemp in Florida has created an estimated $370 million economic impact, supported over 9,000 jobs, and generated over $17 million in federal, state, and local tax revenue.”

Florida’s Agricultural Commissioner expects this year to have an increase in multicultural public education and outreach on the benefits of hemp. Hemp, Inc. has a strong foothold on the educational front with its Hemp University. The Company has held six successful hemp training symposiums in North Carolina and five in Oregon and will continue these educational symposiums throughout the entire state of Florida in order to support their hemp producers, processors, and retailers as demand continues to expand.  Hemp, Inc. is proving to be one of the (hopefully many) dominate players in Florida that will help hemp farmers avoid a lot of the pitfalls they’ve faced in other states. 

“We will also advance research and testing, ensuring Florida hemp products meet the rigorous quality and safety standards that the law requires and consumers deserve. I’m proud of our department’s work on this new green economic driver, and I believe that Floridians will enjoy the benefits of this commodity for generations to come. The sky’s the limit for Florida hemp and we’re very excited about year two,” said Commissioner Fried.

The processing facilities throughout the state are expected to be from the Florida Panhandle down to Homestead, Florida as this will benefit local hemp farmers and the Kins Communities as each hemp farmer needs a processing center nearby. 

The Kins Communities will also be a great resource to people in the state and will boost Florida’s hemp production once they are built out and fully operational. The foundations, for now, include over forty Kins Communities in Florida which have been set up so far. This infrastructure is important for Florida hemp farmers, as the FDACS has approved more than 800 hemp cultivation permits for farmers in 65 of Florida’s 67 counties, with more than 30,000 acres approved for planting.

Moreover, Hemp Inc. is making their King of Hemp® line available at retail stores across America later this year. For those who prefer shopping online, King of Hemp products are currently available at NaturalExposureCBD.com.

Included in the King of Hemp® line are items such as Bubba Kush hemp, CBD pre-rolls, fortified CBD pre-rolls, CBD and CBG Caviar and Moon Rocks, as well as Diamonds, which are the only product on the market today that contain 96%-98.7% CBD.

To learn more, go to the King of Hemp® website, here.

According to Hemp Inc. executives, a distributor is selling a very limited number of signed Billy Hayes CBG pre-rolls as a collector’s item. Also available are CBD pre-rolls that are signed by Bruce Perlowin, and next in the series will be the Notorious Smith Brothers. Those items will be announced and sold at a later date. In addition to their pre-rolls, the King of Hemp line also includes tinctures that contain full-spectrum hemp oil that has been extracted from the flowers and leaves of sustainably sourced hemp plants.

All King of Hemp products are compliant with the Colorado Department of Agriculture regulations and all CBD products contain 0.3% or less THC and are compliant with the 2018 Farm Bill. Those interested in King of Hemp® pre-rolls; hemp-derived CBD tinctures; Caviar; Diamonds; can visit www.kingofhempusa.com and email [email protected].

What is Hemp, Inc.?

Hemp, Inc. is a publicly-traded company, founded in 2008, that has grown to become one of the most recognizable global leaders in the industrial hemp industry with a 62,000 square-foot raw hemp processing center in Medford, Oregon and approximately 10,000 square feet of space contracted for the production of finished goods in Las Vegas, Nevada

With bold moves and decisive action taken this year so far, the Company had substantial revenues for its first quarter of 2021. Last year, Hemp, Inc. focused most of its resources and personnel on growing and processing a very successful high CBD hemp grow in Southern Oregon as opposed to building a massive infrastructure. Those bold moves and strategic actions laid the foundation for this year with the launch of its King of Hemp®, unique and one of kind, CBD and CBG products.

Included in the King of Hemp® line are items such as Bubba Kush hemp, CBD and CBG pre-rolls, fortified CBD pre-rolls, CBD and CBG Caviar and Moon Rocks, as well as Diamonds, which are the only products on the market today that contain 96%-98.7% CBD.

To learn more, go to the King of Hemp® website, here.

According to Hemp Inc. executives, a distributor is selling a very limited number of signed Billy Hayes CBG pre-rolls as a collector’s item. Also available are CBD pre-rolls that are signed by Bruce Perlowin (former CEO of Hemp, Inc. now Chief Visionary Consultant to Hemp, Inc.).  Next in the series will be the Notorious Smith Brothers. In addition to their pre-rolls, the King of Hemp® line also includes tinctures that contain full-spectrum hemp oil that has been extracted from the flowers and leaves of sustainably sourced hemp plants.

All King of Hemp® products are compliant with the Colorado Department of Agriculture regulations and all CBD products contain 0.3% or less THC and are compliant with the 2018 Farm Bill. Those interested in King of Hemp® pre-rolls; hemp-derived CBD tinctures; Caviar; or Diamonds, can visit www.kingofhempusa.com or email [email protected].

Hemp Inc. will be making their King of Hemp® line available at retail stores across America this year. For those who prefer shopping online, King of Hemp® products are currently available at NaturalExposureCBD.com and www.kingofhempusa.com.

The Company is focusing 90% of its efforts on marketing and generating revenues.  “We’re now mass marketing and I’m certain we will have substantial revenue to report for the second quarter and beyond.”  While there may be a few more infrastructure footprints created, it’s full speed ahead for Hemp, Inc.

While Hemp, Inc.’s primary focus is industrial hemp, the Company has recently been promoting the health benefits of legal cannabis by educating the public on the medicinal benefits to marijuana use. Hemp, Inc. has a variety of new medicinal products under their King of Hemp® line to address a multitude of public health concerns that can be remedied in part with the use of cannabis products, and expects to have display booths at all of the upcoming concerts and events at the Veteran Village Kins Communities.

HEMP, INC.’S ELEVEN DIVISIONS

It has been Hemp, Inc.’s intent to continually invest in building its hemp infrastructure, especially since none existed previously. In fact, the Company has instinctively been following the same path as Amazon… reinvesting profits and operating capital back into building the infrastructure. This is a business strategy that has been proven and works well.

All the years leading up to this point were building and finishing the largest hemp infrastructure in America.  Now the Company is focusing 90% of its efforts on marketing and generating revenues.

Hemp, Inc.’s eleven divisions are as follows:

Division One –           The Industrial Hemp Infrastructure

Division Two –           The Hemp Farming Infrastructure

Division Three –        The Hemp Extraction & Pre-Roll Blending Infrastructure

Division Four –          The Hemp Educational Infrastructure

Division Five –           The Hemp Marketing Infrastructure

Division Six –             Accessories, Products and Services

Division Seven –        Research and Development

Division Eight –          Industrial Hemp Investments and Joint Ventures

Division Nine –           Industrial Hemp Consulting

Division Ten –            Educational Entertainment

Division Eleven –       Medical and Recreational Marijuana

Division One – The Industrial Hemp Infrastructure

The Industrial Hemp Infrastructure (Division One) consists of two hemp processing facilities across the country. The largest of the two is its multi-purpose industrial hemp processing facility and milling operation in Spring Hope, North Carolina. It’s the largest “industrial hemp processing center” in the western hemisphere and has grown to become one of the pre-eminent centers of the industrial hemp industry. The 85,000 square foot facility sits on 9 acres. It is environmentally sustainable and was built from the ground up in hopes of “Making America Hemp Again.”  With a patent pending manufacturing process, the North Carolina facility is operating full time to process the Company’s unique kenaf-hemp blend and manufacture all-green natural loss circulation material (LCMs), called DrillWall™ .  The DrillWall™ is to be sold to the oil and gas drilling industry, along with an all-green natural oil spill absorbent, a second industrial kenaf-hemp product called Spill-Be-Gone™.

In addition to the company’s industrial hemp processing facility in Spring Hope, North Carolina, Hemp, Inc. also has a 62,000 square-foot raw hemp processing center in Medford, Oregon (which focuses on hemp harvesting, drying, curing, trimming, bagging, storing, and in some cases selling high CBD hemp for local farmers and the Company’s own hemp grown in that area, and post-processing for the CBD industry) and approximately 10,000 square feet contracted for the production of finished goods in Las Vegas, Nevada. 

The Company’s main focus is the “King of Hemp® pre-rolls and high CBD smokable buds… a new phenomenon of smoking hemp which has caught the marketplace by storm.

Division One Products:

·       DrillWall™ (a loss circulation material)

·       Spill-Be-Gone™ (an oil spill cleanup product)

·       Hemp/kenaf bioplastics

Division Two – The Hemp Farming Infrastructure

The Hemp Farming Infrastructure (Division Two) consists of numerous acres of hemp and kenaf growing in multiple locations, farm equipment, cloning rooms, clones and seeds, grow rooms, greenhouses, hemp drying facilities and a huge amount of peripheral farming tools and equipment. The progress Hemp, Inc. has made in its agricultural endeavors, over the course of five years, has been amazing. This year marks the sixth year that Hemp, Inc. has been growing hemp. Visit https://www.hempincpresents.com/ to see the videos of Hemp, Inc.’s grows in multiple locations.)

Hemp, Inc. operates “Small Family Hemp Farm” models.  The “Small Family Hemp Farm” in North Carolina is situated on 12 acres and consists of a cloning room, a greenhouse, and enough land to grow 2,000-3,000 high CBD or CBG hemp plants.  The model shows farmers how to grow high CBD and CBG hemp plants, operate a greenhouse and turn a barn into a cloning room to earn up to $100,000+ a year.  This shows an example of how the “Small Family Hemp Farm” can be duplicated and reappear on the American landscape. After all, the original small family farms in America were able to survive economically by growing hemp as their main cash crop and the first five presidents of the United States were all hemp farmers.

Another model “Small Family Hemp Farm” is located Dolan Springs, Arizona.  This “Small Family Hemp Farm” is referred to as “The Orchard” since it has a sizable organic orchard.  There are 2 acres on which hemp will be grown; a cloning room; cold storage; and a greenhouse that is planned to be installed. This year mostly CBG hemp will be grown.

“This year is about sales and marketing for us.  Right now, we believe we have the largest footprint of bio-diverse hemp products with vertical integration in the hemp industry in America today. We are always looking for joint ventures where we have or can expand our footprint,” commented a Hemp, Inc. executive.

Moreover, “A to Z” services for the farmers are available – from harvesting to drying, curing, bucking, machine trimming, hand trimming, bagging, storing, nitrogen sparging, and selling… creating a “one stop shop” for the small to large family farms.

Division Two Products include:

·       The King of Hemp® Pre-Roll Blends

Visit www.kingofhempusa.com for current products.

Division Three – The Hemp Extraction & Pre-Roll Blending Infrastructure

The Hemp CBD Oil Extraction & Pre-Roll Blending Infrastructure (Division Three) originally consisted of a Supercritical C02 Extractor. After operating for over a year it has been determined that Hemp, Inc. will not be involved in the extraction industry and has changed its direction to focus primarily on the King of Hemp® pre-rolls and The King of Hemp® high CBD smokable flower. The CBD oil that was extracted from the 2018 hemp grows in North Carolina has been made into pure crystalline CBD isolate which was added to the Company’s “King of Hemp®” branded line of pre-rolls that are now in the marketplace across all 50 states.

Division Four – The Hemp Educational Infrastructure

The Hemp Educational Infrastructure (Division Four) includes Hemp, Inc.’s Hemp University which focuses on educating and empowering Hemp farmers and entrepreneurs with knowledge, processing, infrastructure and support.  The educational seminars, through the Hemp University, are held as needed.  These seminars teach farmers and landowners how to create a profitable income stream by maximizing the per-acre crop revenue. Through this division, Hemp, Inc. has trained well over 500 farmers in its first two years by doing a total of nine Hemp University seminars in North Carolina and Oregon, which included:

The New Leaf Symposium and Golden Grow Awards Gala – January 26, 2020 (Jacksonville, Oregon)

“The New Leaf Symposium’s” focus was “Regeneration” to celebrate optimism and resilience in the industry, the power of the plant, and faith in the hemp-producing community. The event sold out with over 180 attendees. The feedback from attendees was overwhelmingly possible and the speakers were hailed as the best yet. The educational symposium concluded with the “Golden Grow Awards Gala”. The Golden Grow Awards Gala honored Oregon’s top cultivars and put Oregon’s best farmers head-to-head for some of the most prestigious hemp-industry accolades. There were four categories judged in the awards: Top CBD, Top Terpenes, Judge’s Favorite, and Peoples’ Choice.  (See Bruce Perlowin’s personal Facebook post on 1/28/20 for a short video on this symposium.)

The Pre-Harvest Symposium – September 8, 2019 (Oregon)

“The Pre-Harvest Symposium” workshop at Southern Oregon University was expertly designed for both farmers and entrepreneurs of all experience levels, focused on harvesting, processing and profit channels within the hemp industry. The third edition of the Southern Oregon Hemp University brought an abundance of insight into innovations within the realm of harvesting and processing to the forefront. Additionally, the symposium touched on traditional practices in agriculture. (See Bruce Perlowin’s personal Facebook post on 9/9/19 for a short video on this symposium.)

Pre-Plant Support Workshop – May 4, 2019 (Oregon)

“The Pre-Plant Support Workshop” was an incredible success that filled the entire venue to capacity with attendees. In total, there were close to 200 attendees, including 20 vendors in attendance. The workshop was designed to help hemp farmers or those who are interested in the hemp industry learn the best pre-planting practices prior to the planting season. The Hemp University Pre-Planting Support Workshop was an interactive and informative workshop that covered the various details hemp farmers should know prior to planting in the 2019 season and beyond. (See Bruce Perlowin’s personal Facebook post on 5/9/19 for a short video on this workshop.)

The Hemp University Educational Seminar – March 23, 2019 (Oregon)

This was the first Hemp University held on the West Coast.  The seminar provided attendees with a full day of networking, education, and support. The seminar helped others in the area who were interested in the hemp industry learn more about the “Industrial Hemp Revolution” and how this movement can not only transform Southern Oregon’s economy, but also revive family farms and small businesses in the surrounding areas. (See Bruce Perlowin’s personal Facebook post on 3/28/19 for a short video on this seminar.)

Growing Hemp for Profit – March 10, 2018 – (North Carolina)      
The Hemp University’s first educational symposium event of 2018 entitled “Growing Hemp for Profit” took place on Saturday, March 10, 2018. Attendees learned from the University’s industrial hemp experts as they shared their lessons from their experiences in growing industrial hemp. “Growing Hemp for Profit,” which took place from 8:30am to 5 pm at the Hilton Garden Inn in Charlotte, North Carolina. (See Bruce Perlowin’s personal Facebook post on 3/17/18 for a short video on this symposium.)

Hemp Money Event: Economics, Lessons & Planning for 2018 – December 2, 2017 – (North Carolina)

The fifth most vital and anticipated educational symposium of the year was Hemp Money Event: Economics, Lessons & Planning for 2018. This symposium was held on Saturday, December 2, 2017 from 8:30am to 5:00pm at the Shrine Club (320 Airport Rd, Rocky Mount, NC 27804). Attendees learned the economics of growing industrial hemp for fiber, seeds, and CBD; learned about other master POD growers’ experiences and lessons; and, learned how to prepare for the 2018 industrial hemp growing season with a well-defined blueprint for success. (See Bruce Perlowin’s personal Facebook post on 12/23/17 for a short video on this symposium.)

The Hemp Oil Event: The Art and Science of CBD Oil – September 30, 2017 (North Carolina)

The Hemp Oil Event (The Art & Science of CBD Oil) was The Hemp University’s fourth symposium in North Carolina, held on Saturday, September 30, 2017 from 8:30am to 5:00pm at the Peachtree Hills Country Club, 3512 Peachtree Hills Road, Spring Hope, NC 27882.  The symposium brought attendees up to speed on all business and scientific aspects of Industrial Hemp CBD cannabinoids by disseminating current, reliable information that continues to shape the revolutionary CBD market. Attendees also got a chance to go to Hemp, Inc.’s, then, 70,000 square foot multipurpose industrial hemp decortication facility for the first live public demonstration of its Supercritical CO2 Extraction System using North Carolina-grown CBD industrial hemp. Representatives from NuAxon Bioscience were also on-site to allow those interested in purchasing their own CBD extraction system. (See Bruce Perlowin’s personal Facebook post on 9/30/17 for a short video on this symposium.)

The Art and Science of CBD Greenhouse Growing – June 24, 2017 (North Carolina)

The 3rd Hemp University educational symposium held on June 24, 2017 focused on The Art and Science of CBD Greenhouse Growing. The educational symposium was held at Louisburg College in Louisburg, North Carolina. A team of experts engaged attendees through the greenhouse and indoor growing process from cultivation to harvest and from processing to distribution. Dr. Robert Bruck, Dean of Science, Technology, Engineering and Mathematics and Distinguished Professor of Environmental Science at Louisburg College, was The Hemp University’s special guest who lectured on soil microbiology during the symposium. Attendees were able to spend half of the course at Hemp, Inc.’s, then, 70,000 square-foot Industrial Hemp Hub, in a 3,000 square-foot cloning room. There, attendees had the opportunity to experience a more hands-on learning approach. (See Bruce Perlowin’s personal Facebook post on 6/30/17 for a short video on this symposium.)

Farming Hemp for Profit™ – April 29, 2017  (North Carolina)

Hemp, Inc.’s second, sold out, educational symposium (Farming HEMP for Profit™), through its Hemp University, was a phenomenal success. The symposium took place on Saturday, April 29, 2017, from 8:30am – 5:00pm, at the Hampton Inn & Suites located at 3920 Arrow Drive, Raleigh, NC 27612 and drew over 100 attendees. The one-day educational symposium and tour of Hemp, Inc.’s, then, 70,000 square-foot multipurpose industrial hemp facility was an opportunity for landowners and farmers to learn how to apply real business building tactics with a “specific step-by-step blueprint” on how to grow, sell and profit from farming industrial hemp. This event accomplished its mission to help landowners and farmers add a new viable and profitable income stream by maximizing the per-acre crop revenue. (See Bruce Perlowin’s personal Facebook post on 4/30/17 for a short video on this symposium.)

Farming Hemp for Profit™ – March 18, 2017 (North Carolina)

This was Hemp, Inc.’s first Hemp University symposium.  The symposium was a sold out event and was a huge success with 100 attendees who rated the quality of information presented as excellent. The symposium took place on Saturday, March 18, 2017, from 8:00am – 5:00pm, at Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, located at 1436 Highway 581 North, Spring Hope, North Carolina, 27882. The one-day educational symposium was an opportunity for landowners and farmers to receive a “specific step-by-step blueprint” on how to grow, sell and profit from farming industrial hemp by using real business tactics and principles, presented by industry experts. (See Bruce Perlowin’s personal Facebook posts on 3/18-19 and 3/21-26, 2019 for a short videos on this symposium.)

To listen to past Hemp University workshops, please visit hemp-university.teachable.com. Also visit https://www.hempincpresents.com to see highlights from Hemp, Inc.’s inaugural Hemp University held in North Carolina, which sold out in two weeks.

The Hemp University’s twelve online educational masterclasses are $10 each and each masterclass is under an hour in length. The online courses include lectures from industry leaders who have educated attendees at the Hemp University workshops in Oregon. These online masterclasses provide farmers who were either not able to attend the first Hemp University or who would like to revisit certain topics presented by the event speakers.

Those interested in Hemp, Inc.’s online courses, including experts in any aspect of the industrial hemp industry, should contact (855) 554-6834.

“Since The Hemp University’s initial launch with the educational symposium, the number of attendees grew tremendously and was an overwhelming success, each time. The interactive, hands-on learning approach was invaluable. By learning in an interactive cohort format, students gained the necessary skills they needed to immediately implement them on their farm or in their organization. It’s the perfect mix of quality instruction, relevant educational content and a high level of commitment, to ensure the educational success of each attendee,” said one Company executive.

The Hemp University has helped transform the livelihoods of North Carolina and Oregon farmers transitioning from tobacco and other crops to industrial hemp by providing them with the tools and support needed to gain a foothold in this burgeoning industry. 

Division Five – The Hemp Marketing Infrastructure

While marketing is a critical facet of any business operation for increasing revenues, Hemp, Inc. believes there must be a keen focus on the infrastructure.  The demand for CBD, CBG and other hemp products is massive, some even say the demand is insatiable.  In order to supply that type of volume/demand, there has to be a strong foundation or infrastructure in place.  The cannabidiol (CBD) market is on track to grow to $23.7 billion through 2023, according to the Brightfield Group.  The firm also estimated the smokable hemp market to be valued at $11.5 million in 2018, a growth of 250% from 2017.

Division Six – Accessories, Products and Services

Division Six focuses on the sale of hemp industry accessories such as the sale of extractors, harvesters, storage bags, containers, fertilizer, soil amendments, humidifiers, dehumidifiers, balers, greenhouses, and greenhouse equipment; the drying, trimming, curing, storing and brokering for other farmers harvesting hemp; and ultimately anything else a hemp farmer may need to be successful. 

Division Seven – Research and Development

While Research and Development has been an integral part of Hemp, Inc. since day one, the Company plans on developing a more formal research and development project. This division will then start and expand rapidly. The Company originally planned for Puerto Rico to be a research and development hub, but found the barrier to entrance was much too great and has therefore changed its position to focus its research and development division on states where hemp is already legal. Hemp, Inc. is proud to have been a pioneer and leader in the early stages of the hemp industry in America with our strategy to build infrastructure even before legalization occurred in a state such as what was done in North Carolina and Arizona.

Division Eight – Industrial Hemp Investments and Joint Ventures

Hemp, Inc. established its eighth division (Industrial Hemp Investments and Joint Ventures).  Since the passing of the 2018 hemp bill, Hemp, Inc. has been flooded with inquiries of people who want to invest in the hemp industry but don’t know where to start. As the Avant-guard of the industrial hemp industry, Hemp, Inc. has put together numerous joint venture investment opportunities for the medium to large-scale investor. Those who are interested should email [email protected]. Millionaire investors, and in some cases billionaires and billion dollar hedge fund managers, are aggressively trying to get into the hemp industry since the passing of the 2018 Farm Bill. Our joint venture agreements are that they put up the money and we put up the expertise in a 50/50 revenue share (after all the initial investment money is paid back).  This will save the large-scale hemp investor often two years and dozens of multi-million dollar mistakes that they “WILL” often make without an expert in the hemp industry. This is where Hemp, Inc.’s vast network of experts and resources, built over a period of 10 years, in the industrial hemp industry come into play because this is something we can easily provide to those interested in entering this industry.

Division Nine – Industrial Hemp Consulting

Hemp, Inc.’s Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) was recently restructured as its ninth division and is now “Division Nine – Industrial Hemp Consulting”.  With an influx of public companies wanting to expand into the industrial hemp industry, Hemp, Inc. has been inundated with potential consulting and joint venture agreements. To keep up, Hemp, Inc. revamped its consulting division to work hands-on with each company to provide its years of expertise. There is definitely a sense of a “Community of Companies” whereby a lot of companies are working together to pool their resources, marketing connections and strategies in order to grow simultaneously.

Typically, companies seeking in depth consulting services from Hemp, Inc. pay mostly in stock since cash flow is oftentimes tight during the developmental stage of start-up companies in this industry. Through Hemp, Inc.’s Division Nine – Industrial Hemp Consulting, a wide range of services are forged from the experiences of creating the first publicly traded company in the cannabis sector (Medical Marijuana, Inc.) and having over a decade of experience in the industrial hemp industry’s public sector.

Division Ten – Educational Entertainment

The Educational Entertainment division will cover everything from investing in the movie “The Adventures of the King of Pot” (https://www.kingofpotthemovie.com/) and other historical movies, books and documentaries representing our industry up to the current docuseries being made on “The Modern Day History of Hemp”.  Those interested in investing in any one of these ventures should contact [email protected].

Division Eleven – Medical and Recreational Marijuana

Hemp, Inc.’s newest division, Medical and Recreational Marijuana, is underway to enter the cannabis market in 2021 once marijuana is fully legalized across the country.  Banks and merchant account providers will be more open and accepting of marijuana companies. Right now, the banking regulations for marijuana companies are very draconian. “I’ve known so many banks to close accounts merely because they were associated with the industry. Anyway, we don’t know if we’ll wait for full legalization yet but that decision won’t discount the building out of facilities and preparation for it.  After legalization occurs and large scale marijuana grows are underway, this division would already be positioned as a ‘go-to’ consultant due to our industry expertise.”

PREVIOUS PRESS COVERAGE

Between the Hemp University, the hemp processing center and Bruce Perlowin himself, the Company has created an enormous amount of media coverage. See below for the list of press hits the Company has received up to the end of this quarter:

Hit: Hemp: the burgeoning industry of southern Oregon” – (NBC) KOBI-5, December 22, 2018

Press Release: “Hemp, Inc. Featured on Oregon NBC 5 Station Following Passage of 2018 Farm Bill”

https://www.hempinc.com/hemp-inc-featured-on-oregon-nbc-5-station-following-passage-of-2018-farm-bill/

Hit: Carolina’s next cash crop?: Farm bill will add hemp into more growers’ rotation” – The Wilson Times, December 26, 2018

Press Release: “Hemp, Inc. Receives Prominent News Coverage Discussing Hemp Legalization and Small Family Farms”

https://www.hempinc.com/hemp-inc-receives-prominent-news-coverage-discussing-hemp-legalization-and-small-family-farms/

Hit: Arizona’s next cash crop? Lawmaker pushes for rush on hemp bill” – ABC 15, January 28, 2019

Press Release: “Hemp, Inc. Applauds Arizona Legislative Drive to Push Up Industrial Hemp Licensing Date to June 2019 as Veteran Village Kins Community Builds Out Infrastructure”

https://www.globenewswire.com/news-release/2019/02/25/1741708/0/en/Hemp-Inc-Applauds-Arizona-Legislative-Drive-to-Push-Up-Industrial-Hemp-Licensing-Date-to-June-2019-as-Veteran-Village-Kins-Community-Builds-Out-Infrastructure.html

Hit: Farmers could plant hemp in Arizona fields this summer, if bill passes – ABC KUGN-9, February 8, 2019

Hit: Adams on Agriculture – Bruce Perlowin/Hemp, Inc.” – Adams On Agriculture, February 22, 2019

Press Release: “Hemp, Inc. CEO Featured on National Radio Show Discussing Company’s Expanding Footprint and Demand for Cannabidiol”

https://www.globenewswire.com/news-release/2019/02/27/1743589/0/en/Hemp-Inc-CEO-Featured-on-National-Radio-Show-Discussing-Company-s-Expanding-Footprint-and-Demand-for-Cannabidiol.html

Hit: Hemp, Inc. seeking JV partners for processing facilities, CEO says” – MergerMarket, February 28, 2019

Hit: Hemp, Inc. holds first west coast educational seminar in Ashland” –  (NBC) KOBI-5, March 23, 2019

Press Release: “Hemp, Inc. Featured by CBS and NBC Affiliates in Oregon About The Hemp University’s Educational Hemp Seminar”

https://www.hempinc.com/hemp-inc-featured-by-cbs-and-nbc-affiliates-in-oregon-about-the-hemp-universitys-educational-hemp-seminar/

Hit: Hemp University: getting schooled on cannabis” – CBS News 10, March 26, 2019

Press Release: “Hemp, Inc. Featured by CBS and NBC Affiliates in Oregon About The Hemp University’s Educational Hemp Seminar”

https://www.hempinc.com/hemp-inc-featured-by-cbs-and-nbc-affiliates-in-oregon-about-the-hemp-universitys-educational-hemp-seminar/

Hit: How Hemp Is Giving Renewed Life To America’s Tobacco Farmers” – Forbes, March 25, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured in Forbes Discussing Tobacco Farmers Who are Turning to Industrial Hemp”

https://www.hempinc.com/hemp-inc-ceo-bruce-perlowin-featured-in-forbes-discussing-tobacco-farmers-who-are-turning-to-industrial-hemp/

Hit: Market for hemp still a ways off” – Tri-State Neighbor, March 28, 2019

Hit: Tobacco growers may find new avenue in hemp farming” – AgDaily, April 26, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured in AgDaily Discussing Hemp as Agricultural Industry’s Newest Cash Crop”

https://www.hempinc.com/hemp-inc-ceo-bruce-perlowin-featured-in-agdaily-discussing-hemp-as-agricultural-industrys-newest-cash-crop/

Hit: Industrial hemp has potential to be a big cash crop for area farmers” – Tulsa World, May 12, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured in Tulsa World Discussing Oklahoma’s Industrial Hemp Industry”

https://www.hempinc.com/hemp-inc-ceo-bruce-perlowin-featured-in-tulsa-world-discussing-oklahomas-industrial-hemp-industry/

Hit: Growing hemp in the desert” – Today’s News-Herald/Havasu News, June 10, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured on Cover of Today’s News-Herald Discussing Arizona’s Industrial Hemp Industry”

https://www.globenewswire.com/news-release/2019/06/17/1869821/0/en/Hemp-Inc-CEO-Bruce-Perlowin-Featured-on-Cover-of-Today-s-News-Herald-Discussing-Arizona-s-Industrial-Hemp-Industry.html

Hit: Hempathon” contest planned for Golden Valley” – Mohave Daily News, July 7, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured in Mohave Daily News and CBD Today Discussing Hempathon”

https://finance.yahoo.com/news/hemp-inc-ceo-bruce-perlowin-165236585.html

Hit: Hemp, Inc. Seeking Agriculture Suppliers and Farmers for Hempathon Event” – CBD Today, July 2, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured in Mohave Daily News and CBD Today Discussing Hempathon”

https://finance.yahoo.com/news/hemp-inc-ceo-bruce-perlowin-165236585.html

Hit: Hemp Inc. to Hold “Hempathon” in Mohave County” – Arizona Cannabis News, July 15, 2019

Hit: Hemp, Inc. taking hemp into bioplastics” – Plastics News, August 22, 2019

Press Release: “Hemp, Inc. Featured in Plastics News Regarding Entry Into Hemp Bioplastics Industry to Help Fill Growing Demand for Eco-friendly Materials”

https://www.hempinc.com/hemp-inc-announces-hemp-cultivation-now-legal-in-new-jersey-through-expanded-regulations/

Hit: “ROSEBUD ORIGINAL VIDEO: Hemp University the Pre-Harvesting Symposium” – Mail Tribune, September 9, 2019

Press Release: “Hemp, Inc. Subsidiary, The Hemp University, Featured in Mail Tribune Showcasing Pre-Harvest Symposium Hemp Workshop”

https://www.hempinc.com/hemp-inc-subsidiary-the-hemp-university-featured-in-mail-tribune-showcasing-pre-harvest-symposium-hemp-workshop/

Hit: “Hemp In The Valley” – CBS News 10, September 12, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Featured on CBS News 10 in Oregon Discussing State’s Booming Hemp Industry”

https://www.hempinc.com/hemp-inc-ceo-bruce-perlowin-featured-on-cbs-news-10-in-oregon-discussing-states-booming-hemp-industry/

Hit: “Episode 72 : “King of pot, smuggling 101, and getting arrested on an airplane” – Off Script With Trish Glose, CBS News 10 Podcast, September 25, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin to be Featured on the Podcast “Off Script with Trish Glose” This Wednesday”

https://www.hempinc.com/hemp-inc-ceo-bruce-perlowin-to-be-featured-on-the-podcast-off-script-with-trish-glose-this-wednesday/

Hit: “Why US Tobacco Farmers Are Switching To Hemp” – Business Insider, September 16, 2019

Press Release: “Hemp, Inc. Affiliate, Through a Joint Venture, Featured on Business Insider for North Carolina Farming Operations”

https://www.hempinc.com/hemp-inc-affiliate-through-a-joint-venture-featured-on-business-insider-for-north-carolina-farming-operations/

Hit: “HEMP, INC. Joins The Stock Day Podcast to Discuss The Distribution of Their Hemp Pre-Rolls” – Stock Day Podcast, September 27, 2019

Press Release: “HEMP, INC. Joins The Stock Day Podcast to Discuss The Distribution of Their Hemp Pre-Rolls”

https://www.hempinc.com/hemp-inc-joins-the-stock-day-podcast-to-discuss-the-distribution-of-their-hemp-pre-rolls/

Hit: “Hemp hardwoods, bioplastics expand crop use beyond CBD” – United Press International, October 2, 2019

Press Release: “Hemp, Inc. Featured in Globally Syndicated News Provider, United Press International, Discussing Industrial Applications for Bioplastics”

https://www.hempinc.com/hemp-inc-featured-in-globally-syndicated-news-provider-united-press-international-discussing-industrial-applications-for-bioplastics-2/

Hit: “Rising High: An Exclusive Talk with Industrial Hemp Company Hemp, Inc.” – The Fly, October 17, 2019

Press Release: “Hemp, Inc. Profiled in Financial News Outlet, The Fly”

https://www.hempinc.com/hemp-inc-profiled-in-financial-news-outlet-the-fly-2/

Hit: “Lack of Processing Facilities For Hemp” – ABC News Watch 12, October 30, 2019

Press Release: “Hemp, Inc. Oregon Processing Operation Featured in NewsWatch 12’s Harvest Coverage”

https://www.hempinc.com/hemp-inc-oregon-processing-operation-featured-in-newswatch-12s-harvest-coverage/

Hit: “Hemp farmers in red tape” – CBS News 10, November 5, 2019

Press Release: “Hemp, Inc.’s Commentary on New USDA Rules Featured in KTVL Broadcast and Smoky Mountain News”

https://finance.yahoo.com/news/hemp-inc-commentary-usda-rules-133259687.html

Hit: “Legislature to ban smokable hemp in N.C.” – Smoky Mountain News, November 6, 2019

Press Release: “Hemp, Inc.’s Commentary on New USDA Rules Featured in KTVL Broadcast and Smoky Mountain News”

https://finance.yahoo.com/news/hemp-inc-commentary-usda-rules-133259687.html

Hit: “Hemp Inc. CEO, Bruce Perlowin Interview” – The Light, November 13, 2019

Press Release: “Hemp, Inc. CEO Bruce Perlowin Joins News Video Series, The Light, to Discuss Company Initiatives”

https://finance.yahoo.com/news/hemp-inc-ceo-bruce-perlowin-124612561.html

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information” and Hemp, Inc. does… using the SEC’s Alternative Reporting Standard to publicly report its quarterly and yearly financials.  All current information can be found on www.hempinc.com/hemp-financial-disclosures/. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Contact Name: Hemp, Inc.

Phone: 855-436-7688

Email: [email protected]

Cannabis

IM Cannabis Reports 2023 Financial Results

Published

on

im-cannabis-reports-2023-financial-results

TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ — IM Cannabis Corp. (the “Company” or “IMC“) (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of consolidated audited financial statements for the years ended December 31, 2023 and 2022 (the “Annual Financial Statements“) and accompanying management’s discussion and analysis (the “Annual MD&A“) can be accessed by visiting the Company’s website at https://investors.imcannabis.com/, and its profile pages on SEDAR+ at www.sedarplus.ca, and EDGAR at http://www.sec.gov/edgar.

FINANCIAL HIGHLIGHTS FOR THE THREE MONTHS AND YEAR ENDED DECEMBER 31, 2023

  • Revenue decreased to $48.8 million for the fiscal year ended December 31, 2023 (compared to $53.3 in 2022), representing a decrease of 10%.
    • Primarily due to negative currency fluctuations and the impact of the Israel-Hamas war on the Company’s operations.
  • Revenue decreased to $10.7 million for the three months ended December 31, 2023 (compared to $14.5 million in 2022), representing a decrease of 26%.
    • Primarily due to the interruption on the Company’s supply chain caused by the Israel-Hamas war and the Company discounting certain outstanding inventory at lower prices.
  • Gross profit increased to $9.8 million for the fiscal year ended December 31, 2023 (compared to $9.2 million in 2022), representing an increase of 7.5%
  • Gross profit decreased to $0.8 million for the three months ended December 31, 2023 (compared to $2.6 million in 2022), representing a decrease of 68%
    • Primarily due to the interruption on the Company’s supply chain caused by the Israel-Hamas war and the Company discounting certain outstanding inventory at lower prices.
    • The Company’s fair value adjustment was approximately $1 million for the fiscal year ended December 31, 2023 (compared to $2.1 million in 2022).
  • G&A expenses decreased to $11 million for the fiscal year ended December 31, 2023 (compared to $21.5 million in 2022), representing an decrease of 49%
  • G&A expenses decreased to $3.3 million for the three months ended December 31, 2023 (compared to $9.8 million in 2022), representing a decrease of 66%
    • Primarily due to the impairment on Y2022 and restructuring and HC adjustments in 2023.
  • Selling and marketing expenses decreased to $10.8 million for the fiscal year ended December 31, 2023 (compared to $11.5 million in 2022), representing an decrease of 6%
  • Selling and marketing expenses decreased to $2.8 million for the three months ended December 31, 2023 (compared to $3.1 million in 2022), representing a decrease of 10%
    • Primarily due to a decrease in share based compensation payments and a restructuring of the Company’s personnel.
  • Net Loss from continuing operations for the fiscal year ended December 31, 2023 was $10.2 million, as compared to $24.9 million in 2022.
  • Net Loss from continuing operations for the three months ended December 31, 2023 was $3.5 million, as compared to a Net Loss of $9.6 million in the fourth quarter of 2022.
  • Diluted Loss per Share for the fiscal year ended December 31, 2023 was $0.74, compared to a loss of $3.81 per Share in 2022.
  • Diluted Loss per Share for the three months ended December 31, 2023  was $(0.25), compared to a basic loss of $)2.94( per share and a diluted loss of $)3.55( per share in for the three months ended December 31, 2022.
  • Cash and Cash Equivalents as of December 31, 2023, was $1.8 million, compared to $2.4 million as of December 31, 2022. 
  • Total assets were $48.8 million as of December 31, 2023, compared to $60.7 million as of December 31, 2022, representing a decrease of 20%.
    • Primarily attributed to an inventory reduction of about $6.6 million, a reduction in other current assets of $1.8 million and a reduction of non-current assets of about $3.5 million
  • Total Liabilities were $35.1 million as of December 31, 2023, compared to $36.9 as of December 31, 2022, representing a decrease of about 5%. 
    • Primarily attributed to a reduction in trade payables of $6.1 million.
  • Operating expenses decreased to $22.6 million for the year ended December 31, 2023 (compared to $40 million in 2022), representing a decrease of 43%
  • Operating expenses decreased to $6 million for the three months ended December 31, 2023 (compared to $13.3 million in 2022), representing a decrease of 55%
  • Adjusted EBITDA1 decreased to $8 million for the year ended December 31, 2023, (compared to $11.5 in 2022), representing a decrease of 30%
  • Total Dried Flower sold in 2023 was approximately 8,609 kg with an average selling price of $5.14 per gram (compared to approximately 6,794kg, with an average selling price of $7.12 per gram in 2022).
    • Primarily due to increased competition within the retail segment and the Company discounting certain outstanding inventory at lower prices.
  • Total Dried Flower sold in the fourth quarter of 2023 was about 2,082kg with an average selling price of $4.52 per gram (compared to about 2,334kg with an average selling price of $5.19 per gram in 2022).
    • Primarily due to increased competition within the retail segment and the Company discounting certain outstanding inventory at lower prices.

The Annual Financial Statements include a note regarding the Company’s ability to continue as a going concern. The Annual Financial Statements do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern. For more information, please refer to the “Liquidity and Capital Resources” and “Risk Factors” sections in the 2023 Annual MD&A.

Management Commentary

“IMC Germany delivered accelerated growth in 2023, growing 181% from $252K in 2022 to $709K in 2023. During this time, IMC Germany was #1 in sales per stock keeping unit and posted the highest growth against its competitors in the German market.2 With the regulatory rescheduling of cannabis in Germany set to occur effective April 1st, the Company hopes to continue its growth in the market as the market evolves,” said Oren Shuster, Chief Executive Officer of IMC. “In addition, as we are constantly looking for opportunities to maximize shareholder value, we are hopeful that our potential reverse merger with Israel-based Kadimastem Ltd., a clinical cell therapy public company traded on the Tel Aviv stock exchange under the symbol (TASE: KDST) will proceed as expected, which we believe will create significant value for the shareholders.”

“As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full year results. Due to the ongoing conflict, there was a 6% decrease in our yearly revenue. Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022. However, our gross profit for 2023 increased by 7.5% to $9.8 million as compared to last year,” said Uri Birenberg, Chief Financial Officer of IMC. “Partially offsetting these declines, we were able to reduce our operating costs in the fourth quarter of 2023 by 55% as compared to the fourth quarter of 2022, ending the year with a 43% reduction in our operating costs as compared to last year, as we leaned further into our goal of active cost management.”

Conference Call 

The Company will host a Zoom web conference call today at 9:00 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Non-IFRS Measures

This press release makes reference to “Gross Margin” and “Adjusted EBITDA”, which are financial measures that are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. These measures are provided as complementary information to the Company’s IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should neither be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS.

For an explanation of how management defines Gross Margin and Adjusted EBITDA, see the 2023 MD&A.

We reconcile these non-IFRS financial measures to the most comparable IFRS measures as set out below:

About IM Cannabis Corp.

IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations as discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the Company leaving the Canadian cannabis market to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany; the impact of the Israel-Hamas war on the Company, including its operations and the medical cannabis industry in Israel; the timing and impact of the partial legalization of medicinal cannabis in Germany, including, the Company having it “all in house”, the Company being positioned to take advantage of the partial legalization, the Company’s growth in 2024, the market growth for medicinal cannabis in Germany, and the stated benefits of the Company’s EU-GMP processing facility and an EU-GDP logistics center; the Company to host a teleconference meeting as stated; and the Company’s stated goals, scope, and nature of operations in Germany, Israel, and other jurisdictions the Company may operate.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to focus and resources to achieve sustainable and profitable growth in its highest value markets; the Company’s ability to mitigate the impact of the Israel-Hamas war on the Company; the Company’s ability to take advantage of the partial legalization of medicinal cannabis in Germany; the Company’s ability to host a teleconference meeting as stated; and the Company’s ability to carry out its stated goals, scope, and nature of operations in Germany, Israel, and other jurisdictions the Company may operate.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include:  the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the Israel-Hamas war on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company’s inability to take advantage of the partial legalization of medicinal cannabis in Germany; and the Company’s inability to host a teleconference meeting as stated.

Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

1 Earnings before interest, taxes, depreciation, and amortization (“EBITDA“) and Adjusted EBITDA. These measures do not have a standardized meaning prescribed by International Financial Reporting Standards (“IFRS“) and are therefore unlikely to be comparable to similar measures presented by other issuers. Non-IFRS measures provide investors with a supplemental measure of the Company’s operating performance and therefore highlight trends in Company’s core business that may not otherwise be apparent when relying solely on IFRS measures. Management uses non-IFRS measures in measuring the financial performance of the Company.

2 Based on reporting by Insight Health’s as of December 31, 2023.

 

Company Contact: 

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
[email protected]

 

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Canadian Dollars in thousands

December 31,

Note

2023

2022

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$    1,813

$        2,449

Trade receivables

6

7,651

8,684

Advances to suppliers

936

1,631

Other accounts receivable

7

3,889

3,323

Inventory

9

9,976

16,585

24,265

32,672

NON-CURRENT ASSETS:

Property, plant and equipment, net

10

5,058

5,221

Investments in affiliates

15c

2,285

2,410

Right-of-use assets, net

12

1,307

1,929

Deferred tax assets, net

17

763

Intangible assets, net

11

5,803

7,910

Goodwill

11

10,095

9,771

24,548

28,004

Total assets

$       48,813

$       60,676

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Canadian Dollars in thousands

December 31,

Note

2023

2022

LIABILITIES AND EQUITY

CURRENT LIABILITIES:

Trade payables

14

$        9,223

$       15,312

Credit from banks and others

13

12,119

9,246

Other accounts payable and accrued expenses

15

6,218

6,013

Accrued purchase consideration liabilities

5

2,097

2,434

PUT Option liability

2,697

Current maturities of operating lease liabilities

12

454

814

32,808

33,819

NON-CURRENT LIABILITIES:

Warrants measured at fair value

17

38

8

Operating lease liabilities

12

815

1,075

Credit from banks and others

394

399

Employee benefit liabilities, net

16

95

246

Deferred tax liability, net

19

963

1,332

2,305

3,060

Total liabilities

35,113

36,879

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:

20

Share capital and premium

253,882

245,776

Translation reserve

95

1,283

Reserve from share-based payment transactions

9,637

15,167

Accumulated deficit

(249,145)

(239,574)

Total equity attributable to shareholders of the Company

14,469

22,652

Non-controlling interests

(769)

1,145

Total equity

13,700

23,797

Total equity and liabilities

$       48,813

$       60,676

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME

Canadian Dollars in thousands

Year ended December 31,

Note

2023

2022

 *) 2021

Revenues

21

$       48,804

$       54,335

$       34,053

Cost of revenues

21

37,974

43,044

25,458

Gross profit before fair value adjustments

10,830

11,291

8,595

Fair value adjustments:

Unrealized change in fair value of biological assets

(315)

6,308

Realized fair value adjustments on inventory sold in the year

(984)

(1,814)

(8,570)

Total fair value adjustments

(984)

(2,129)

(2,262)

Gross profit after fair value adjustments

9,846

9,162

6,333

General and administrative expenses

21

11,008

21,460

17,221

Selling and marketing expenses

21

10,788

11,473

6,725

Restructuring expenses

1

617

4,383

Share-based compensation

20

225

2,637

5,422

Total operating expenses

22,638

39,953

29,368

Operating loss

(12,792)

(30,791)

(23,035)

Finance income

7,006

6,703

23,544

Finance expenses

(3,671)

(1,972)

(673)

Finance income (expense), net

3,335

4,731

22,871

Loss before income taxes

(9,457)

(26,060)

(164)

Income tax expense (benefit)

18

771

(1,138)

500

Net loss from continuing operations

(10,228)

(24,922)

(664)

Net loss from discontinued operations, net of tax

25

(166,379)

(17,854)

Net loss

(10,228)

(191,301)

(18,518)

*)       Reclassified in respect of discontinued operations – see Note 25.

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME

Canadian Dollars in thousands, except per share data

Year ended December 31,

Note

2023

2022

 *) 2021

Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:

Remeasurement gain on defined benefit plans

38

59

21

Exchange differences on translation to presentation currency

(894)

(1,238)

858

Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods

(856)

(1,179)

879

Other comprehensive income that will be reclassified to profit or loss in subsequent periods:

Adjustments arising from translating financial statements of foreign operation

231

(246)

530

Total other comprehensive income (loss)

(625)

(1,425)

1,409

Total comprehensive loss

$     (10,853)

$    (192,726)

$      (17,109)

Net loss attributable to:

Equity holders of the Company

$      (9,498)

$    (188,890)

$      (17,763)

Non-controlling interests

(730)

(2,411)

(755)

$       (10,228)

$    (191,301)

$      (18,518)

Total comprehensive loss attributable to:

Equity holders of the Company 

$        (10,648)

$    (190,162)

$      (16,357)

Non-controlling interests 

$        (205)

(2,564)

(752)

$        (10,853)

$    (192,726)

$     (17,109)

Earnings (loss) per share attributable to equity holders of the Company from continuing operations:

22

Basic earnings (loss) per share (in CAD)

$              (0.74)

$          (3.13)

$            0.02

Diluted loss per share (in CAD)

$              (0.74)

$          (3.81)

$           (3.62)

Loss per share attributable to equity holders of the Company from discontinued operations:

Basic and diluted loss per share (in CAD)

$        (23.17)

$          (3.08)

Loss per share attributable to equity holders of the Company from net loss:

Basic earnings (loss) per share (in CAD)

$              (0.74)

$        (26.3)

$          (3.06)

Diluted loss per share (in CAD)

$              (0.74)

$        (26.98)

$          (6.7)

*)       Reclassified in respect of discontinued operations – see Note 25.

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

Canadian Dollars in thousands

Share capital and premium

Treasury Stock

Reserve from share-based payment transactions

Translation reserve

Accumulated deficit

Total

Non-controlling interests

Total
equity

Balance as of January 1, 2021

$     37,040

$              –

$       5,829

$       1,229

$   (33,001)

$     11,097

$       1,513

$     12,610

Net loss

(17,763)

(17,763)

(755)

(18,518)

Total other comprehensive income

1,385

21

1,406

3

1,409

Total comprehensive income (loss)

1,385

(17,742)

(16,357)

(752)

(17,109)

Issuance of common shares, net of issuance costs of $3,800

195,259

195,259

2,948

198,207

Purchase of treasury common shares

(660)

(660)

(660)

Exercise of warrants and compensation options

4,293

4,293

4,293

Exercise of options

1,053

(920)

133

133

Share-based compensation

7,471

7,471

7,471

Expired options

32

(32)

Balance as of December 31, 2021

237,677

(660)

12,348

2,614

(50,743)

201,236

3,709

204,945

Net loss

(188,890)

(188,890)

(2,411)

(191,301)

Total other comprehensive income (loss)

(1,331)

59

(1,272)

(153)

(1,425)

Total comprehensive loss

(1,331)

(188,831)

(190,162)

(2,564)

(192,726)

Issuance of treasury common shares

660

660

660

Issuance of shares, net of issuance costs of $178

6,818

6,818

6,818

Exercise of options

992

(659)

333

333

Share-based compensation

3,767

3,767

3,767

Expired options

289

(289)

Balance as of December 31, 2022

245,776

15,167

1,283

(239,574)

22,652

1,145

23,797

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

Canadian Dollars in thousands

Share capital
and
premium*)

Reserve from
share-based
payment
transactions

Translation
reserve

Accumulated
deficit

Total

Non-controlling interests

Total
equity

Balance as of December 31, 2022

245,776

15,167

1,283

(239,574)

22,652

1,145

23,797

Net loss

(9,498)

(9,498)

(730)

(10,228)

Total other comprehensive income (loss)

(1,188)

38

(1,150)

525

(625)

Total comprehensive loss

(1,188)

(9,460)

(10,648)

(205)

(10,853)

Issuance of treasury common shares

2,351

2,351

2,351

Issuance of shares, net of issuance costs of $178

Exercise of options

Other comprehensive income Classification

(111)

(111)

(1,709)

(1,820)

Share-based compensation

225

225

225

Expired options

5,755

(5,755)

Balance as of December 31, 2023

253,882

9,637

95

(249,145)

14,469

(769)

13,700

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

Canadian Dollars in thousands

Year ended December 31,

2023

2022

2021

Cash provided from operating activities:

Net loss

$     (10,228)

$ (191,301)

$   (18,518)

Adjustments for non-cash items:

Unrealized gain on changes in fair value of biological assets

(84)

(7,210)

Fair value adjustment on sale of inventory

984

4,342

8,796

Fair value adjustment on warrants, investments, and accounts receivable

(6,955)

(6,000)

(21,638)

Depreciation of property, plant and equipment

644

3,044

3,021

Amortization of intangible assets

1,758

2,343

1,158

Depreciation of right-of-use assets

594

1,944

1,550

Impairment of goodwill

107,854

275

Impairment of property, plant and equipment

2,277

Impairment of intangible assets

7,199

Impairment of right-of-use assets

1,914

Finance income, net

3,019

6,532

1,262

Deferred tax payments (benefit), net

394

(3,004)

278

Share-based payments

225

3,767

7,471

Share based acquisition costs related to business combination

807

Revaluation of other accounts receivable

3,982

Restructuring expenses

8,757

Loss from revaluation of investments

601

1,264

144,867

(4,230)

Changes in non-cash working capital:

Increase (decrease) in trade receivables, net

2,320

6,058

(6,602)

Increase (decrease) in other accounts receivable and advances to suppliers

1,299

3,622

845

Decrease in biological assets, net of fair value adjustments

565

6,412

Increase (decrease) in inventory, net of fair value adjustments

4,771

883

(19,707)

Increase (decrease) in trade payables

(6,098)

11,284

5,573

Changes in employee benefit liabilities, net

(139)

(63)

28

Increase in other accounts payable and accrued expenses

(750)

12,126

2,661

1,403

34,475

(10,790)

Taxes paid

(514)

(681)

(834)

Net cash used in operating activities

(8,075)

(12,640)

(34,372)

The accompanying notes are an integral part of the consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

Canadian Dollars in thousands

Year ended December 31,

2023

2022

2021

Cash flows from investing activities:

Purchase of property, plant and equipment

(581)

(1,562)

(4,578)

Proceeds from sales of property, plant and equipment

210

Proceeds from loans receivable

350

7,796

Purchase of intangible assets

(17)

Acquisition of businesses, net of cash acquired

(12,536)

Deconsolidation of subsidiary (see Note 25)

(406)

Investments in financial assets

(13)

Proceeds from sale of investment

319

Proceeds from (investment in) restricted deposits

17

Investments in associates

(601)

(125)

Net cash used in investing activities

(1,182)

(1,533)

(9,012)

Cash provided by financing activities:

Proceeds from issuance of share capital, net of issuance costs

1,688

3,756

28,131

Proceeds from issuance of warrants measured at fair value

6,585

11,222

Proceeds from exercise of warrants

3,682

Proceeds from exercise of options

333

133

Repayment of lease liability

(586)

(1,656)

(633)

Payment of lease liability interest

(63)

(1,429)

(1,347)

Proceeds from loans

5,482

9,636

7,804

Repayment of loans

(4,827)

(4,976)

Interest paid

(1,664)

(902)

(261)

Proceeds from discounted checks

2,802

Net cash provided by financing activities

9,417

4,762

48,731

Effect of foreign exchange on cash and cash equivalents

(796)

(2,043)

(329)

Increase (decrease) in cash and cash equivalents

(636)

(11,454)

5,018

Cash and cash equivalents at beginning of year

2,449

13,903

8,885

Cash and cash equivalents at end of year

$      1,813

$      2,449

$    13,903

Supplemental disclosure of non-cash activities:

Right-of-use asset recognized with corresponding lease liability

$         309

$         613

$      1,678

Conversion of warrant and compensation options into common shares

$                 –

$             –

$         611

Issuance of shares in payment of purchase consideration liability

$                 –

$      3,061

$             –

Issuance of shares in payment of debt settlement to a non-independent director of the company

$      1,061

$             –

$             –

 

 

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-reports-2023-financial-results-302102584.html

Continue Reading

Cannabis

Hemp, Inc. Announces Significant Progress in Hemp Seed Meal Approval for Laying Hen Diets

Published

on

Continue Reading

Cannabis

Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania